These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7473434)
1. Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa. Hordnes K; Digranes A; Haugen IL; Helland DE; Ulstein M; Jonsson R; Haneberg B J Reprod Immunol; 1995 Mar; 28(3):247-62. PubMed ID: 7473434 [TBL] [Abstract][Full Text] [Related]
2. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine. Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481 [TBL] [Abstract][Full Text] [Related]
3. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice. Hordnes K; Tynning T; Brown TA; Haneberg B; Jonsson R Vaccine; 1997 Aug; 15(11):1244-51. PubMed ID: 9286051 [TBL] [Abstract][Full Text] [Related]
4. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289 [TBL] [Abstract][Full Text] [Related]
5. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Haneberg B; Kendall D; Amerongen HM; Apter FM; Kraehenbuhl JP; Neutra MR Infect Immun; 1994 Jan; 62(1):15-23. PubMed ID: 8262621 [TBL] [Abstract][Full Text] [Related]
6. Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women. Hordnes K; Tynning T; Kvam AI; Jonsson R; Haneberg B Infect Immun; 1996 May; 64(5):1643-52. PubMed ID: 8613373 [TBL] [Abstract][Full Text] [Related]
7. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization. Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709 [TBL] [Abstract][Full Text] [Related]
8. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant. Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794 [TBL] [Abstract][Full Text] [Related]
9. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate. Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Wallerström G; Holmgren J Vaccine; 2001 May; 19(25-26):3360-8. PubMed ID: 11348699 [TBL] [Abstract][Full Text] [Related]
10. Induction of IgA and IgG antibodies in vaginal fluid, serum and saliva following immunization of genital and gut associated lymphoid tissue. Bergmeier LA; Tao L; Gearing AJ; Adams S; Lehner T Adv Exp Med Biol; 1995; 371B():1567-73. PubMed ID: 7502858 [TBL] [Abstract][Full Text] [Related]
11. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. Elson CO; Ealding W J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359 [TBL] [Abstract][Full Text] [Related]
12. Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity. Smith DJ; Lam A; Barnes LA; King WF; Peacock Z; Wise DL; Trantolo DJ; Taubman MA Oral Microbiol Immunol; 2003 Aug; 18(4):240-8. PubMed ID: 12823800 [TBL] [Abstract][Full Text] [Related]
13. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Zhou F; Kraehenbuhl JP; Neutra MR Vaccine; 1995 May; 13(7):637-44. PubMed ID: 7668033 [TBL] [Abstract][Full Text] [Related]
14. A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin. Berstad AK; Holst J; Møgster B; Haugen IL; Haneberg B Vaccine; 1997; 15(12-13):1473-8. PubMed ID: 9302763 [TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Price GA; Russell MW; Cornelissen CN Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481 [TBL] [Abstract][Full Text] [Related]
16. Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Wu HY; Abdu S; Stinson D; Russell MW Infect Immun; 2000 Oct; 68(10):5539-45. PubMed ID: 10992451 [TBL] [Abstract][Full Text] [Related]
17. Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage. Externest D; Meckelein B; Schmidt MA; Frey A Infect Immun; 2000 Jul; 68(7):3830-9. PubMed ID: 10858191 [TBL] [Abstract][Full Text] [Related]
19. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Russell MW; Moldoveanu Z; White PL; Sibert GJ; Mestecky J; Michalek S M Infect Immun; 1996 Apr; 64(4):1272-83. PubMed ID: 8606090 [TBL] [Abstract][Full Text] [Related]
20. Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration. McConnell EL; Basit AW; Murdan S Vaccine; 2008 Jan; 26(5):639-46. PubMed ID: 18178292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]